Clinical Trials Logo

HPV Testing clinical trials

View clinical trials related to HPV Testing.

Filter by:
  • None
  • Page 1

NCT ID: NCT05727228 Recruiting - Cervix Cancer Clinical Trials

Screening Triage and Risk Stratification

I-share
Start date: February 27, 2023
Phase:
Study type: Observational [Patient Registry]

- To investigate the performance of cytology, extended genotyping, p16/Ki67 dual stain cytology, DNA methylation and viral load as triage markers in post-menopausal HPV-screen-positive women aged 50-64 years in the organized screening program to predict the risk of developing CIN2+. (work package 1) - To investigate the performance of cytology, extended genotyping, p16/Ki67 dual stain cytology, DNA methylation and viral load six months after cervical excision to predict the long-term risk of residual/recurrent CIN2+ lesions among women aged 23-64 (work-package 2)

NCT ID: NCT02613611 Not yet recruiting - HPV Testing Clinical Trials

HPV Screening (Human Papilloma Virus)

HPV
Start date: November 2015
Phase: N/A
Study type: Observational

Examination of cervical &urine samples for HPV

NCT ID: NCT02155231 Recruiting - HPV Testing Clinical Trials

Study on Anal Human Papillomavirus Infection and Anal Intraepithelial Neoplasia Among Men Who Have Sex With Men in Indonesia, Malaysia, and Thailand

Start date: February 2013
Phase:
Study type: Observational

OBJECTIVES 1. To determine the prevalence and incidence of anal HPV infection, including infection with high-risk HPV types, among MSM in Indonesia, Malaysia, and Thailand. 2. To study the prevalence and incidence of HGAIN among these MSM. 3. To evaluate risk factors, including HIV status, for anal high-risk HPV infection and HGAIN among these MSM. Study population An approximately 75 HIV-positive and 75 HIV-negative MSM who attended the study clinic in Kuala Lumpur, Jakarta, and Bangkok will be enrolled. The study will also enroll 185 HIV-positive and 95 HIV-negative MSM who are previous participants of the MSM VCT study. There will be approximately 260 HIV-positive and 170 HIV-negative MSM in total in this study.